Block of Ca2I currents by the dihydropyridine drug nitrendipine was studied in single canine ventricular cells by using the whole-cell variant of the patch clamp technique. When cells were held at depolarized membrane potentials at which Ca2+ currents were -70% inactivated, nitrendipine blocked Ca2+ currents very potently, with half-block by subnanomolar concentrations. The concentration dependence of block had the form expected for 1:1 binding, with Ca2+ channels are found in many kinds of cells and are important for electrical excitability, excitation-contraction coupling, excitation-secretion coupling, and other cellular functions (1, 2). The development of drugs that block Ca2+ channels has provided a valuable route for studying channel function, and there has been rapidly increasing clinical use of Ca2+ channel blockers in combating hypertension, angina, and arrhythmias (3). Recently, there has been particular interest in the family of dihydropyridine drugs related to nifedipine, especially since the discovery that [3H]nitrendipine and other radioactively labeled derivatives bind with very high affinity (Kd = 0.1-1 nM) to sites in brain, heart, smooth muscle, and other tissues (4-7). Based on the Ca2+ channel-blocking activity of the drugs, it is widely hoped that the binding site now being purified in several laboratories with the aid of radioactive labeling (8, 9) will be a Ca2 + channel protein.
Ca2+ channels are found in many kinds of cells and are important for electrical excitability, excitation-contraction coupling, excitation-secretion coupling, and other cellular functions (1, 2) . The development of drugs that block Ca2+ channels has provided a valuable route for studying channel function, and there has been rapidly increasing clinical use of Ca2+ channel blockers in combating hypertension, angina, and arrhythmias (3) . Recently, there has been particular interest in the family of dihydropyridine drugs related to nifedipine, especially since the discovery that [3H]nitrendipine and other radioactively labeled derivatives bind with very high affinity (Kd = 0.1-1 nM) to sites in brain, heart, smooth muscle, and other tissues (4) (5) (6) (7) . Based on the Ca2+ channel-blocking activity of the drugs, it is widely hoped that the binding site now being purified in several laboratories with the aid of radioactive labeling (8, 9) will be a Ca2 + channel protein.
However, the relationship between dihydropyridine binding and block of Ca2+ channels has been unclear. In tissues like heart and brain, there is no known effect of low concentrations of dihydropyridines on physiological function despite the presence of high-affinity binding sites at a fairly high density (10, 11) . Also, all voltage clamp studies so far have found that the dihydropyridine concentrations needed to block Ca2 + currents are 100-1000 times higher than would be expected from the binding data (12, 13) . This discrepancy has raised the possibility that the high-affinity binding site is not related to block of Ca2+ channels.
Studying Ca2 + channels in voltage-clamped dog ventricular cells, I have found that Ca2" current can be blocked by nanomolar concentrations of nitrendipine if the cells are held at membrane potentials at which most channels are inactivated. Interpreted by a modulated receptor hypothesis like that devised to account for voltage-and frequency-dependent features of local anesthetic block of Na' channels (14, 15) , the results suggest that nitrendipine binds to the inactivated state of the Ca2l channel with a Kd of 0.25 nM. Just as for [3H]nitrendipine binding to the high-affinity site, the kinetics of Ca2+ current block by low nitrendipine concentrations are found to be slow, requiring many minutes to reach equilibrium. In addition to clarifying the relation between high-affinity binding and channel blocking activity, the results may shed light on the tissue specificity with which dihydropyridines affect physiological function.
METHODS
Isolation of Cells. Beating hearts were removed from mongrel dogs of either sex and placed into ice-cold modified Tyrode's solution containing (in mM) 150 NaCl, 4 KCl, 2 CaCl2, 2 MgCl2, 10 glucose, 10 Hepes (pH 7.3). A piece of muscle about 1 cm square was removed from near the center of the right ventricle, placed in 0 Ca Tyrode's solution (same as above but with CaC12 omitted), and minced with scissors into 1-mm pieces, which were then transferred into 10-ml beakers containing the enzyme solution [modified from Bustamente et al. (16) ] of 0.05 mg of protease (Sigma type VII) per ml and 0.6 mg of collagenase (Sigma type I) per ml in 0 Ca Tyrode's solution. The pieces were stirred at 37°C for 20 min, triturated about 20 times with a broken-off Pasteur pipette, incubated another 20 min, triturated again, and then filtered through 200-,um nylon mesh. The filtrate was spun at -1000 rpm for 3 min and the pellet was resuspended in 0.5 mM Ca Tyrode's solution. Cells were kept at room temperature and used within 24 hr; only relaxed, striated, rod-shaped cells were used.
Current Recording. Whole-cell voltage clamp currents were recorded following the method of Hamill et al. (17) . Cells were placed in 2 mM Ca Tyrode's solution and approached with fire-polished electrodes (2-4 MfQ) containing (in mM) 120 CsCl, 10 Cs2EGTA, 5 MgCl2, 10 Hepes (pH 7.4).
After formation of a gigaseal and rupture of the membrane, the currents were allowed to stabilize (2-10 min) and the external solution was then changed to the recording solution containing (in mM) 2-20 CaCl2 or BaCl2, 135 tetraethylammonium chloride, 2 MgCl2, 10 glucose, 10 Hepes (pH 7.4). These ionic conditions allowed optimal recording of Ca2+ currents: Na+ current was completely eliminated, K+-channel currents were completely or nearly completely suppressed (see Fig. 1A Inset) , and the input resistance of the cells was usually 1-5 GO. Bathing solution flowed through the chamber (capacity, -1 ml) at a constant rate of 5-15 ml/min throughout the experiment. Depolarizing pulses were given at intervals of 9-30 s to avoid possible use-dependent effects. Membrane currents were filtered at 1 KHz, digitized at intervals of 100-300 As, and stored and analyzed on a
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Proc. Natl. Acad. Sci. USA 81 (1984) 6389 laboratory computer. For measurement of peak Ca2+ current, leak and capacity currents were subtracted by using current from hyperpolarizing pulses, and peak inward current was read as the average of -10 points around the peak.
Experiments were done at 220C. Drug Application. Nitrendipine (kindly supplied by Alexander Scriabine, Miles Laboratories, New Haven, CT) was dissolved as a 2 or 10 mM solution in ethanol, prepared daily and protected from light. Aliquots were serially diluted in the external aqueous solution to the final concentration. In control experiments at depolarized holding potentials, concentrations of ethanol 100 times higher than those in the largest nitrendipine solutions were found to have no effect on Ca2 + current; at hyperpolarized potentials, ethanol concentrations equivalent to those in the 10 AtM nitrendipine solution had no effect. Separate chambers, solution reservoirs, and tubing were used for experiments with low (0.3-10 nM) and high (0.1-30 ,M) nitrendipine concentrations and were rinsed repeatedly with ethanol between nitrendipine applications. RESULTS
Block at Depolarized Holding Potentials. Fig. 1 illustrates potent nitrendipine block of Ca2+ currents in cells held at depolarized membrane potentials. The experiment in Fig. 1A was done with a cell held at -10 mV, at which Ca2+ current was about 70% inactivated compared with the current elicited from a holding potential of -80 mV. As in other kinds of cells that are internally dialyzed (18) (19) (20) , the size of the Ca2+ current showed a slow decline even in the absence of drug. Fortunately, this decline was slow enough that drug block of current could be clearly distinguished from continuing baseline rundown. The amount of block (to 23% of control in Fig. lA) could be estimated by recording control currents for a long period (26 min in Fig. 1A , of which the final 11 min are shown) before drug was applied and assuming that normal rundown continued to occur during drug block. In two other applications of 1 nM nitrendipine under similar conditions, block to 19% and 25% of control was observed.
The experiment in Fig. lA was typical of the other experiments with 1 nM nitrendipine in showing a relatively slow block of current (half-time, 21/2-4 min) after nitrendipine was applied; this was much longer than the time needed for exchange of solution in the chamber (half-time, 15 -45 s).
Larger drug concentrations blocked more completely and more quickly. When cells could be voltage-clamped for long enough, washing the cell with drug-free solution after nitrendipine block almost always resulted in some recovery of current size, as in Fig. 1B . The recovery of current on rinsing suggests that nitrendipine acts by a reversible blocking action on Ca2l channels, rather than (for example) simply accelerating the normal rundown process. The time course of recovery was always slow, as in Fig. 1B , with current continuing to increase for 10-20 min; because of the slowness of recovery and the underlying continual rundown of Ca2 current, recovery was never more than partial.
The results in Fig. 1 A and B were typical of >40 applications of nanomolar concentrations of nitrendipine to dog heart cells held at depolarized membrane potentials. Fig. 1C shows the concentration dependence of nitrendipine block in 12 cells bathed in a solution containing 20 mM Ca2". Data were restricted to cells for which long baseline series of control currents were recorded (>7 min) and in which the rate of rundown was slow enough (<3.5%/min) to allow optimal separation of nitrendipine block from normal rundown. The holding potential varied from -10 to -20 mV and was adjusted in each cell so that steady-state inactivation was >2/3 complete. Under these conditions, the dose dependence of nitrendipine block can be fit very well by a curve having the form expected from 1:1 binding, with an apparent Kd of 0.36 nM. In addition to the discrepancy previously reported between nitrendipine concentrations needed for binding or blocking, there has been an apparent difference in modulation of the two processes by divalent ions. Lee and Tsien (13) [drug]i(1 -h) kl) (see Fig. 5 and Discussion). Proc. Natl. Acad. Sci. USA 81 (1984) not much affected by the divalent ion species or concentration. Fig. 2 summarizes experiments comparing block by 1 nM nitrendipine in bathing solutions containing 2 mM Ca2+, 20 mM Ca2 , and 20 mM Ba2 . In all cases, nitrendipine reduced currents to 20-30% of control. Nitrendipine was equally potent in other experiments at depolarized holding potentials using bathing solutions of isotonic (110 mM) BaCl2, suggesting that the tetraethylammonium chloride present in most experiments had little effect on block. Experiments on cells isolated from the right atrium or from the sino-atrial node showed equally potent Ca2+ current block.
Block at More Negative Holding Potentials. When cells were held at negative membrane potentials at which channels were not inactivated, nitrendipine concentrations >1000 times higher were required for equivalent Ca2+ channel block. Fig. 3A shows a typical example in which Ca2+ currents were elicited from a holding potential of -80 mV; application of 1 uM nitrendipine resulted in prompt reduction of current to 50% of control, and currents recovered substantially within a few minutes of rinsing with drug-free solution. In other cells, hyperpolarizing the membrane beyond -80 mV was found to have no effect on current size either in the absence or presence of 1 /iM nitrendipine, suggesting that the effect of holding potential on nitrendipine potency is saturated at -80 mV. In contrast to the slow development of block seen with nanomolar concentrations at depolarized potentials, block by micromolar concentrations at negative holding potentials developed quickly (half-time 15-45 s), with the speed probably limited by the rate of solution exchange. Recovery was also rapid (half time, 45-90 s). If block was induced by 1 nM nitrendipine at more depolarized holding potentials, changing the holding potential to -80 mV resulted in prompt removal of block. arise from Ca2+ flowing through Na+ channels since it was not blocked by 12 ,uM tetrodotoxin. It was not an artifact of capacity or leak current subtraction, since it was eliminated by substituting Co2+ for Ca2+.
As with block at depolarized potentials, block by large concentrations at negative holding potentials was not much affected by changing Ca2+ concentrations or by using Ba2+ as the current-carrying ion. As shown in Fig. 4 
DISCUSSION
The principal finding of this study is that nitrendipine blocks cardiac calcium currents very potently at holding potentials at which most channels are inactivated. At more negative holding potentials, block is less potent by a factor of >1000.
These results can be understood by postulating that nitrendipine binds tightly to the inactivated state of the Ca2 + channel and much more weakly to the resting state. This interpretation is a version of the modulated receptor hypothesis, successfully used to account for voltage-dependent and frequency-dependent aspects of local anesthetic block of Na2+ channels (14, 15, 23, 24) . Fig. 5 shows a version of the modulated receptor model that can account quantitatively for the results described in this paper. With no drug, a Ca2+ channel can be in either the resting state (R), in which it is closed but available to be opened by a depolarization, or in the inactivated state (I), in which it is closed and not available to be opened. Experimentally, the number of channels in state R is assayed by the Ca2+ current elicited by a large depolarization. The distribution of channels between states R and I depends on the steady membrane potential, with more channels in the inactivated state at depolarized holding potentials. The model in Fig. 5 is also consistent with the concentration dependence of the kinetics of block by low nitrendipine concentrations (Fig. 1D) (12) . However, the results reported here seem consistent with recent abstracts by Sanguinetti and Kass (25) and Uehara and Hume (26) reporting voltage-dependent block by nisoldipine and nifedipine. The model in Fig. 5 (4-7, 27, 28) . Also, the kinetics of block (Fig. 1) (21, 29) ; for example, the estimate of 10-s1 for the rate constant k1 is identical to that by Bolger et al. (29) . Further, in the blocking experiments described here and in previous binding studies, both the kinetics and steady-state characteristics of block or binding can be fit accurately by assuming 1:1 bin ing of drug to the high-affinity receptor. Finally, the lack df change in blocking potency when Ca2 + is varied in the millimolar range is consistent with the properties of binding to the highaffinity site (21, 22) . Taken together, all of these observations provide strong support for the idea that the high-Aiffihity dihydropyridine binding site is associated with the inactivated state of the Ca2+ channel, a possibility raised previously by Lee and Tsien (13) . This idea offers a satisfying explanation for the previous discrepancy between blocking and binding. Previous determinations of blOcking potency were carried out from holding potentials at which almost all channels would be in the low-affinity resting state, while binding studies are usually performed by using membrane fragments, in which the Ca2+ channel proteins presumably sense a membrane potential near 0 mV and all channels are inactivated. One binding study employed enzymatically isolated intact cells (30) , but it is possible that the high-affinity binding sites were all associated with the 10% of the cells that are damaged and depolarized in even the best single cell preparations. Alternatively, it is possible that the high-affinity site is present in resting channels but that occupancy does not block the channel. In its simplest form, though, the model in Fig. 5 predicts little or no high-a'fihity binding to well-polarized tissue, and drastically depolarizing intact tissue (as with large K+ concentrations) or purposely disrupting intact cells should result in the appearance of highaffinity binding sites.
The results offer a simple explanation of why low ctncentrations of dihydropyridines affect the contractility of smooth muscle but, so far as is known, have no effect on normal heart or brain function (10, 11, 31) . In the normal heart, it is very unlikely that any region reaches a depolarized membrane potential for long enough to permit significant dihydropyridine binding; though Ca2+ channels certainly become inactivated during the action potential plateau, the time a chaninel spends in the inactivated state (<1 s) is much less than the minutes it takes nitrendipine to bind to inactivated channels (Fig. 1) . The situation in neurons may well be similar. In contrast, dihydropyridine effects on smooth muscle contractility are usually evaluated in vitro by using K+ depolarizations that are maintained for minutes; the slow binding to the inactivated state also offers a ready explanation for why tonic contractures are more potently reduced thanphasic contractures in these experiments (32, 33 
